Skip to content
★ Sign in to follow
VV

Versant Venture Capital V, L.P.

Related company / holding
Crinetics Pharmaceuticals, Inc.Gritstone bio, Inc.CRISPR Therapeutics AG
Total declarations
21
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€951k

Latest filing published 06 Feb 2019 for Crinetics Pharmaceuticals, Inc..

Filing timeline

BuySale
Versant Venture Capital V, L.P.

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

Versant Venture Capital V, L.P.: trading record in brief

Versant Venture Capital V, L.P. is a declared insider at 3 companies; the most frequent names are Crinetics Pharmaceuticals, Inc., CRISPR Therapeutics AG and Gritstone bio, Inc. Over a trading history stretching from 24 April 2018 to 4 February 2019, the count stands at 21 filings.

Sales make up the whole of the open-market record (4 sales, €951k).

The newest entry dates from 6 February 2019: a transaction, in Crinetics Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Versant Venture Capital V, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations